SPA
KIDS icon

Sherbrooke Park Advisers’s OrthoPediatrics KIDS Stock Holding History

Sherbrooke Park Advisers’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,781
Closed -$428K – 974
2024
Q3 		$428K Buy
+15,781
New +$478K 0.1% 379

Other funds holding KIDS

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sherbrooke Park Advisers's KIDS Position: Q4 2024 in Review

Sherbrooke Park Advisers sold out of OrthoPediatrics (KIDS) in Q4 2024, closing a stake of 15,781 shares — an estimated $428K sold.

Sherbrooke Park Advisers first reported a position in KIDS in Q3 2024 and held it in 1 quarter. The position peaked at $428K in Q3 2024. 108 funds tracked by Wall St. Rank hold KIDS as of Q4 2024.

  • Sherbrooke Park Advisers reported no remaining OrthoPediatrics position as of Q4 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 15,781 OrthoPediatrics shares in Q4 2024, an estimated $428K.
  • Sherbrooke Park Advisers first reported a position in OrthoPediatrics in Q3 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's OrthoPediatrics position peaked at $428K in Q3 2024.
  • 108 funds tracked by Wall St. Rank held OrthoPediatrics as of Q4 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.